FOR PATIENTS · SOURCE READING
Beta-blocker therapy
Source: Childhood Vascular Tumors (PDQ®)–Patient Version, National Cancer Institute.
Source updated: March 6, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Types of treatment for childhood vascular tumors / Treatment options
Beta-blockers are drugs commonly used to lower blood pressure and heart rate, but they can also shrink certain types of vascular tumors, such as infantile hemangiomas. Beta-blocker therapy may be injected into a vein, taken by mouth, or placed on the skin (topical). How beta-blocker therapy is given depends on the type of vascular tumor being treated and where it first formed.
Source links and citations
The beta-blocker propranolol is usually the first treatment for hemangiomas. Infants younger than 4 weeks, who have an underlying condition, or who are treated with IV propranolol may need to have their treatment started in a hospital. Infantile hemangioma may also be treated with propranolol and steroid therapy or propranolol and topical beta-blocker therapy. Propranolol is also used to treat benign vascular tumors of liver.
Other beta-blockers used to treat vascular tumors include atenolol, nadolol, and timolol.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle